Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Classifica tra le azioni #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Prezzo delle azioni
$1.30
Ultima sincronizzazione: 2023-10-13
Capitalizzazione di mercato
$38.02M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Zynerba Pharmaceuticals, Inc. (ZYNE)

Categoria

Storico del prezzo dell'azione per Zynerba Pharmaceuticals, Inc. (ZYNE)
Prezzo di chiusura più alto: $1.27 il 2023-10-01

Prezzo di chiusura più basso: $28.18 il 2015-08-01
Storico del prezzo dell'azione di Zynerba Pharmaceuticals, Inc. dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$162.27 24.72%
DE
$38.00 22.72%
JP
$221.29 33.66%
CH
$21.01 11.96%
IN